Navigation Links
The Leukemia & Lymphoma Society Hosts Workshop On Weighing Treatment Options For Chronic Myelogenous Leukemia
Date:9/6/2007

Free, Interactive Workshop Features CML Expert, Jorge Cortes, M.D.

WHITE PLAINS, N.Y., Sept. 6 /PRNewswire/ -- Jorge Cortes, M.D., an expert on leukemia, will discuss novel treatment approaches for chronic myelogenous leukemia (CML) in a free telephone workshop entitled CML: A Model in Cancer Therapy. The program is scheduled for Thursday, Sept. 20, 2007, 12:00 p.m. - 1:00 p.m. ET.

The program is being offered by The Leukemia & Lymphoma Society, the leading source of information and support for patients battling leukemia, lymphoma and myeloma, and is supported by an unrestricted educational grant from Novartis.

Dr. Cortes is the deputy chair for the department of leukemia and professor of medicine and internist at The University of Texas M.D. Anderson Cancer Center in Houston, TX. His presentation will address the latest treatment options, emerging therapies, the role of clinical trials and quality of life considerations. A question-and-answer period will follow.

"Dr. Cortes will discuss the promising advances in CML treatment, and provide guidance on the importance of monitoring CML treatment and progress," says Robin Kornhaber, M.S.W., The Leukemia & Lymphoma Society's senior vice president of patient services.

The program is approved for 1.0 Continuing Education Unit for nurses and social workers upon verification of completion.

Registration

Registrants will receive an information packet and toll-free dial-in number within 48 hours of signing up. Participants can register online through http://www.lls.org/cmllinks or by phone at (866) 992-9950 ext. 302.

About Chronic Myelogenous Leukemia

CML is called by several names, including chronic granulocytic, chronic myelocytic or chronic myeloid leukemia. CML results from a change to the DNA of a stem cell in the marrow. Scientists do not yet understand what produces this change in the DNA, which is not
'/>"/>

SOURCE The Leukemia & Lymphoma Society
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. GLEEVEC - An Oral treatment for leukemia
2. GLEEVEC - An Oral treatment for leukemia
3. Cyclosporin A Treats Leukemia Complications
4. Aspirin Lowers Leukemia Risk
5. Skin Allergies Found To Increase The Risk Of Leukemia
6. Night Light Found To Increase The Risk Of Leukemia
7. Treating Leukemia With Natural Cells
8. Exposure to EMF may cause leukemia
9. A new vaccine for leukemia
10. Leukemia pill shows promise against stomach cancer
11. Hope for Chemo-Resistant Leukemia Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/21/2010)... Family Research Council President Tony Perkins released the following statement in response to reports that President Obama may issue an executive order regarding ... ... , ... ... ...
(Date:3/21/2010)... players, parents and coaches can help prevent injuries ... offer children and teens many health and social ... be aware of the risks, experts advise. , ... school sports-related injuries are reported, and every day ... sports-related injuries, according to the National Athletic Trainers, ...
(Date:3/18/2010)... ... surgery patients. The Plastic Surgery Institute of Southeast Texas provides their patients with a more ... ... surgery procedures. It is also one of the top concerns for people considering plastic surgery. ...
(Date:3/18/2010)... $1 , ... , ... ... WASHINGTON , March 18 Kids in Michigan will take center stage in the fight ...
(Date:3/18/2010)... ... ... ... WASHINGTON , March 18 Kids in New Hampshire will take center stage in the fight against tobacco on March 24 as they join thousands ...
Breaking Medicine News(10 mins):Health News:Executive Order Will In No Way Prevent Federal Funding of Elective Abortion 2Health News:Executive Order Will In No Way Prevent Federal Funding of Elective Abortion 3Health News:Executive Order Will In No Way Prevent Federal Funding of Elective Abortion 4Health News:Safety Should Be Priority for Those Involved in Kids' Sports 2Health News:Plastic Surgery Institute of Southeast Texas Offers Milder Anesthesia for Outpatient Procedures 2Health News:Michigan Kids 'Kick Butts' on March 24 2Health News:Michigan Kids 'Kick Butts' on March 24 3Health News:Michigan Kids 'Kick Butts' on March 24 4Health News:Michigan Kids 'Kick Butts' on March 24 5Health News:New Hampshire Kids 'Kick Butts' on March 24 2Health News:New Hampshire Kids 'Kick Butts' on March 24 3Health News:New Hampshire Kids 'Kick Butts' on March 24 4
... in mice could lead to better diagnosis and treatment, ... A protein that stops the spread of breast cancer ... a new study suggests. , The gene, called bromodomain ... mice, produced a unique gene signature, which was also ...
... MDMA Annual Meeting, WASHINGTON, April 23 ... gather for the 2008,Annual Meeting of the Medical ... at the Marriott at Metro Center in Washington, ... MDMA is the voice for innovative, entrepreneurial medical ...
... the Nursing Shortage By Supporting,1500 New Students in ... The Robert Wood Johnson,Foundation (RWJF) and the American ... creation of the RWJF New Careers in Nursing,Scholarship ... by,dramatically expanding the pipeline of students in accelerated ...
... OSWEGO, Ore., April 23 West Coast Bank,has ... to promote,the organization,s Guardian of Courage Event series ... West Coast Bank Relationship Manager and Vice President,said, ... organizations through West,Coast Bank,s commitment to serving local ...
... What: Heska Corporation Invites You to Listen to Its Annual ... Web, When: Tuesday, May 6, @ 9:00 a.m. (MDT], Where: ... Stockholders link on the front page of this website), ... the web at the address ...
... Annual MeetingENDO 08will be held at the Moscone Convention ... , Reporters can register here: http://www.endo-society.org/media/ENDO-08/ , ... world are expected to assemble for this premier meeting ... It is the opportunity for journalists to learn about ...
Other Medicine News:Health News:Gene Predicts Breast Cancer Prognosis 2Health News:Key Industry and Government Officials to Address Medical Technology Executives 2Health News:Robert Wood Johnson Foundation Partners with AACN to Launch New Careers in Nursing Scholarship Program 2Health News:Robert Wood Johnson Foundation Partners with AACN to Launch New Careers in Nursing Scholarship Program 3Health News:Robert Wood Johnson Foundation Partners with AACN to Launch New Careers in Nursing Scholarship Program 4Health News:Webcast Alert: Heska Corporation's Annual Meeting of Stockholders Webcast 2Health News:ENDO 08: Latest news on hormones, steroids, obesity, diabetes and more 2
(Date:3/17/2010)... March 17, 2010 , ... ... - SORT OUT III Data Presented at American College of Cardiology Meeting,in Atlanta and Published in the Lancet , ... , , ...
(Date:3/17/2010)... to present at the Sidoti Fourteenth Annual New York Emerging Growth Institutional Investor Forum at The Grand Hyatt in New York City on Tuesday, March 23, 2010 . , ... , ... ... ...
(Date:3/17/2010)... (Nasdaq: MITI ) announced today the closing of its previously announced underwritten public offering. Prior to closing, the underwriters ... a total of 11.5 million shares of its common stock at a public offering price of $7.00 per ... ... , , ...
Breaking Medicine Technology:Positive Long Term Data Presented at ACC 2010 Demonstrate Sustained Safety and Efficacy Advantages of the Cypher(R) Sirolimus Drug-Eluting Stent Over the Endeavor(R) Zotarolimus-Eluting Stent 2Positive Long Term Data Presented at ACC 2010 Demonstrate Sustained Safety and Efficacy Advantages of the Cypher(R) Sirolimus Drug-Eluting Stent Over the Endeavor(R) Zotarolimus-Eluting Stent 3Positive Long Term Data Presented at ACC 2010 Demonstrate Sustained Safety and Efficacy Advantages of the Cypher(R) Sirolimus Drug-Eluting Stent Over the Endeavor(R) Zotarolimus-Eluting Stent 4Positive Long Term Data Presented at ACC 2010 Demonstrate Sustained Safety and Efficacy Advantages of the Cypher(R) Sirolimus Drug-Eluting Stent Over the Endeavor(R) Zotarolimus-Eluting Stent 5Positive Long Term Data Presented at ACC 2010 Demonstrate Sustained Safety and Efficacy Advantages of the Cypher(R) Sirolimus Drug-Eluting Stent Over the Endeavor(R) Zotarolimus-Eluting Stent 6Kensey Nash To Participate in the Sidoti Fourteenth Annual New York Emerging Growth Institutional Investor Forum 2Micromet Closes $80.5 Million Public Offering of Common Stock 2Micromet Closes $80.5 Million Public Offering of Common Stock 3Micromet Closes $80.5 Million Public Offering of Common Stock 4Survivors of childhood cancer less likely to marry 10291 1Survivors of childhood cancer less likely to marry 10291 2Survivors of Childhood Cancer Less Likely to Marry 59113 1Survivors of Childhood Cancer Less Likely to Marry 59113 2Survivors of Childhood Cancer Less Likely to Marry 59113 3Survivors of Childhood Cancer Less Likely to Marry 59113 4High Desert Medical Group CEO Dr Richard Merkin Host Over 4 000 Seniors at 19th Annual Senior Health Expo Discuss Savings Using Electronic Medical 59111 1High Desert Medical Group CEO Dr Richard Merkin Host Over 4 000 Seniors at 19th Annual Senior Health Expo Discuss Savings Using Electronic Medical 59111 2High Desert Medical Group CEO Dr Richard Merkin Host Over 4 000 Seniors at 19th Annual Senior Health Expo Discuss Savings Using Electronic Medical 59111 3High Desert Medical Group CEO Dr Richard Merkin Host Over 4 000 Seniors at 19th Annual Senior Health Expo Discuss Savings Using Electronic Medical 59111 4
... Microplate washer MP-1200 is a compact ... system. Its internal micropumps enable the ... discharge from all types of microtiter ... be washed in rows of 8 ...
Wellwash 384 is an efficient, rapid and reliable washing process for high-throughput screening. It has been designed to optimize the washing process and ensure the best results. Available in 384 or 9...
... Designed and manufactured specifically ... MultiWash II delivers the ... demand. The MultiWash II ... dependable accuracy, while providing ...
... PDQ Plus for the determination of A1c is ... The PDQ Plus is a fully automated analyzer ... for the ultimate in safety and positive identification. ... well known to be interference-free and to produce ...
Medicine Products: